(Q44023175)

English

Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

post-transplant lymphoproliferative disorder

0 references

Epstein–Barr virus

0 references

author name string

Ho AY

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Adams S

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Shaikh H

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pagliuca A

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Devereux S

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Mufti GJ

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

867-869

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Epstein-Barr virus-associated B cell lymphoproliferative disease after non-myeloablative allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703552

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703552

21 January 2018

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703552

21 January 2018

Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703552

7 January 2021

based on heuristic

inferred from DOI database lookup

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703552

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703552

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703552

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44023175&oldid=2206393391"